Robert J. DelAversano - Jan 5, 2024 Form 3 Insider Report for Acasti Pharma Inc. (ACST)

Role
Vice President, Finance
Signature
/s/ Robert J. DelAversano
Stock symbol
ACST
Transactions as of
Jan 5, 2024
Transactions value $
$0
Form type
3
Date filed
1/8/2024, 08:00 AM
Previous filing
Feb 9, 2023
Next filing
May 8, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ACST Stock Options (Right to Buy) Jan 5, 2024 Class A Common Shares 42K $2.13 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) Stock options granted on December 19, 2023 under the Acasti Pharma Inc. Stock Option Plan, which options vest in equal quarterly installments over a period of 36 months.